4. Discussion
The total economic burden to the United States alone is approximately one billion dollars per year as a consequence of bone fractures. Accordingly, scientific advances to shorten the fracture healing time would have important consequences on both economy and patient morbidity. There is an abundance of information to suggest that the anabolic growth factor, IGF-I, would accelerate fracture healing [16,19,21, 22] and that osteocytes play an essential role in fracture healing [6,8,15]. We undertook the present study to test the hypothesis that osteocytederived IGF-I plays an enhancing role in the fracture repair process by evaluating the consequence of conditional deletion of Igf1 in osteocytes on the healing of tibial fractures in mice. Of all the disciplines of biology, the one that produces the most unexpected results is genetics. This study with the osteocyte Igf1 cKO mice fulfilled that prophecy. Accordingly, we did not find an impaired fracture healing in our cKO mice as expected. Even more surprising was the finding that the fracture healing as assessed by the valid criterion (i.e., bony union of the fracture gap) was actually accelerated. These surprising results were reproducible and were confirmed in repeat experiments. Bony union is a valid histological surrogate of fracture healing. Thus, it appears that conditional deletion of Igf1 in osteocytes not only did not impede, but in fact unexpectedly accelerated, fracture healing. We should also note that although IGF-I is known to be essential for normal cartilage growth and development, the reduced formation of the cartilaginous callus and the accelerated fracture repair seen in cKO mutants were probably not due to reduction in local production of chondrocyte-derived IGF-I in fracture calluses, since there was no apparent reduction in the IGF-I expression in fracture callus chondrocytes between osteocyte Igf1 cKO mutants and corresponding WT littermates (Suppl. Fig. S1B).